ROBERT CONWAY Insider Trading $ARRY ARRAY BIOPHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT CONWAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT CONWAY. ROBERT CONWAY is Director in ARCA biopharma, Inc. ($ABIO) and CEO in ARRAY BIOPHARMA INC ($ARRY) and CHIEF EXECUTIVE OFFICER in ARRAY BIOPHARMA INC ($ARRY) and Director in Nivalis Therapeutics, Inc. ($NVLS).
ROBERT CONWAY in ARRAY BIOPHARMA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT CONWAY: CEO, CHIEF EXECUTIVE OFFICER
Holdings: 633,386 shares
Current Value: $6,669,555
Latest Transaction: Oct 04 2011
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT CONWAY in ARRAY BIOPHARMA INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ABIO, ARRY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 04 2011 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Grant | A | 0.00 | 57,190 | 0 | 633,386 | 576.2 K to 633.4 K (+9.93 %) |
| Jun 17 2011 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | P | 2.17 | 25,000 | 54,250 | 576,196 | 551.2 K to 576.2 K (+4.54 %) |
| May 16 2011 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | P | 2.86 | 20,000 | 57,200 | 551,196 | 531.2 K to 551.2 K (+3.77 %) |
| Apr 05 2011 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | A | 3.06 | 100,000 | 306,000 | 100,000 | |
| Oct 06 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Grant | A | 0.00 | 57,474 | 0 | 528,996 | 471.5 K to 529 K (+12.19 %) |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | A | 2.74 | 100,000 | 274,000 | 100,000 | |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 7,000 | 0 | 469,346 | 476.3 K to 469.3 K (-1.47 %) |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 14,000 | 0 | 80,000 | 66 K to 80 K (+21.21 %) |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 14,000 | 0 | 476,346 | 490.3 K to 476.3 K (-2.86 %) |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 15,000 | 0 | 66,000 | 51 K to 66 K (+29.41 %) |
| Apr 01 2010 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 15,000 | 0 | 490,346 | 505.3 K to 490.3 K (-2.97 %) |
| Oct 13 2009 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | M | 0.60 | 228,751 | 137,251 | 0 | |
| Oct 13 2009 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Payment of Exercise | F | 2.58 | 125,324 | 323,336 | 505,346 | 630.7 K to 505.3 K (-19.87 %) |
| Oct 13 2009 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | M | 0.60 | 228,751 | 137,251 | 630,670 | 401.9 K to 630.7 K (+56.91 %) |
| Oct 06 2009 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Grant | A | 0.00 | 50,532 | 0 | 401,919 | 351.4 K to 401.9 K (+14.38 %) |
| May 01 2009 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | A | 3.01 | 100,000 | 301,000 | 100,000 | |
| Sep 11 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | A | 6.22 | 100,000 | 622,000 | 100,000 | |
| Apr 17 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | M | 0.60 | 51,249 | 30,749 | 228,751 | |
| Apr 17 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | M | 0.60 | 51,249 | 30,749 | 349,931 | 298.7 K to 349.9 K (+17.16 %) |
| Apr 17 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 6,000 | 0 | 298,682 | 304.7 K to 298.7 K (-1.97 %) |
| Apr 11 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 280,000 | |
| Apr 11 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | M | 0.60 | 20,000 | 12,000 | 304,682 | 284.7 K to 304.7 K (+7.03 %) |
| Apr 11 2008 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Gift | G | 0.00 | 5,000 | 0 | 284,063 | 289.1 K to 284.1 K (-1.73 %) |
| Dec 21 2007 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | M | 0.60 | 10,000 | 6,000 | 300,000 | |
| Dec 21 2007 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | M | 0.60 | 10,000 | 6,000 | 289,063 | 279.1 K to 289.1 K (+3.58 %) |
| Nov 16 2007 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Option Exercise | M | 0.60 | 10,000 | 6,000 | 310,000 | |
| Nov 16 2007 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CEO | Buy | M | 0.60 | 10,000 | 6,000 | 279,063 | 269.1 K to 279.1 K (+3.72 %) |
| Aug 08 2005 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 6.51 | 400,000 | 2,604,000 | 400,000 | |
| Aug 08 2005 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CHIEF EXECUTIVE OFF ... | Gift | G | 0.00 | 6,000 | 0 | 199,071 | 205.1 K to 199.1 K (-2.93 %) |
| Aug 03 2004 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 6.68 | 17,337 | 115,811 | 17,337 | |
| Aug 03 2004 | ARRY | ARRAY BIOPHARMA IN ... | CONWAY ROBERT | CHIEF EXECUTIVE OFF ... | Gift | G | 0.00 | 8,000 | 0 | 204,500 | 212.5 K to 204.5 K (-3.76 %) |
Page: 1